LSE-LSE Technology Approach To Generate Innovative Kinase Inhibitor Drugs (joint with Four Industrial Partners)

StatusFinished
Effective start/end date1/02/1331/07/15

Funding

  • COMMISSION OF THE EUROPEAN COMMUNITIES (305272 LSE): £116,535.00